Gilead To Lengthen Supply of Covid-19 Drug Remdesivir; Negotiating Licenses With Drug Makers in India, Pak

Gilead To Lengthen Supply of Covid-19 Drug Remdesivir; Negotiating Licenses With Drug Makers in India, Pak

Vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. (Image: REUTERS) Gilead last week received the U.S. Food and Drug Administration’s emergency use authorization for using remdesivir as a treatment against COVID-19, after the drugmaker provided data showing the drug…

View More Gilead To Lengthen Supply of Covid-19 Drug Remdesivir; Negotiating Licenses With Drug Makers in India, Pak